Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

3D Systems

Palantir Technologies

Roblox

Velodyne Lidar

More than 550 U.S.-listed companies are reporting quarterly results on the first three days of next week, May 10 through 12.

Earnings Previews: Palantir, Roblox, 3D Systems, Tilray, Velodyne

The merger between Tilray Inc (NASDAQ: TLRY) and Aphria was a “perfect match” and the entity could generate pro-forma sales growth of 33% between fiscal 2021 and 2024, according to Jefferies. The Tilray Analyst: Owen Bennett upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23.

Jefferies Upgrades Tilray On EU, US Prospects

Canopy Growth

GrowGeneration Corp

SNDL Inc.

Cannabis stocks are on the move Friday morning with many of the major players seeing shares increasing on two pieces of news. The post Cannabis Stocks: 2 Big Reasons TLRY, CGC, GRWG, SNDL Stocks Are Getting High appeared first on InvestorPlace.

Cannabis Stocks: 2 Big Reasons TLRY, CGC, GRWG, SNDL Stocks Are Getting High

Wall Street is mostly stoked about the cannabis stock's potential.

Tilray Has 64% Upside After "Perfect Match" Merger, Analyst Says

Tilray shares stepped up by roughly 10% on Friday, bolstered by a double upgrade to "buy" from "underperform" at Jefferies, which said the cannabis company entered into a "perfect" merger with Aphria.  The rating was lifted from underperform in a note published Friday. Jefferies also raised its price target to $23 a share from $4.77, which would represent 63% upside from Thursday's closing price of $14.15.

Tilray climbs 10% as the cannabis company gets a double upgrade to 'buy' from Jefferies (TLRY)

Aphria

Last December, two Canada-based pot growers, Tilray Inc. (NASDAQ: TLRY) and Aphria, announced a merger that closed Monday, with Tilray the surviving company at a market cap of around $8.2 billion.

Analyst Calls Tilray-Aphria Marijuana Merger a ‘Perfect Match' and Upgrades Shares

Arena Pharmaceuticals

GW Pharmaceuticals

HEXO Corp

FSD Pharma

Innovative Industrial Properties

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

22nd Century Group

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.

What Happened with Marijuana Stocks This Week?

Jefferies upgraded shares of the new Tilray Inc. to buy from underperform on Friday, and said the recent merger of the company with rival Aphria Inc. was "the perfect match." Analyst Owen Bennett raised his price target to $23 from $4.77.

Tilray shares soar 10% premarket after Jefferies upgrades to buy, says Aphria merger 'the perfect match'

Tilray jumps 10% after Jefferies lifts to buy on 'perfect' Aphria merger

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) announced that as of today, May 5, 2021, its shares of class 2 common stock (the “Tilray Shares”) have commenced trading on the Toronto Stock Exchange (the “TSX”) under the ticker symbol “TLRY.” The Tilray Shares will continue to trade on the Nasdaq Global Select Exchange under the ticker symbol “TLRY.” As previously announced, each holder of common shares of Aphria Inc. (“Aphria”) received 0.8381 of a Tilray Share for eac

Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”

A mega-merger marks a historic day for the legalized cannabis industry -- and a chance to load up on TLRY stock as a pot-market giant emerges. The post Tilray Becomes Pot's Biggest As Investors Say Good-Bye to Aphria Stock appeared first on InvestorPlace.

Tilray Becomes Pot's Biggest As Investors Say Good-Bye to Aphria Stock

Aurora Cannabis

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Returns in weed stocks have been all over the place, and largely based on geography. Here's where 10 of the biggest names stand now.

The 10 Hottest Weed Stocks On the Market For May

Are Canadian Marijuana Stocks Positioned For Future Gains? The post How Do You Invest In Marijuana Stocks? 2 Canadian Pot Stocks To Watch In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

How Do You Invest In Marijuana Stocks? 2 Canadian Pot Stocks To Watch In May

DraftKings

Virgin Galactic

Not every investor thinks these three stocks have what it takes to generate outsized returns for your portfolio.

Can These 3 Promising Mid-Caps Grow Their Way Into Large-Caps?

The combined company is taking the Tilray name.

The Aphria and Tilray Merger Finally Closes

Tilray, Inc. (NASDAQ: TLRY) and Aphria, Inc. (NASDAQ:APHA) have merged after months of negotiations, creating a company with a combined market cap of $3.3 billion. The two Canadian cannabis giants had been in talks since December with Aphria's current CEO Irwin Simon to create a new enterprise.

Tilray, Aphria Close Merger, Create The 'New' Tirlay

Canadian cannabis companies Tilray Inc. and Aphria Inc. announced the closing of their merger on Monday, creating the world's biggest weed company measured by revenue.

Cannabis Watch: Tilray and Aphria merger closes and creates world's biggest weed company by revenue

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports first-quarter 2021 results.

Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?

The shares of Tilray Inc (NASDAQ:TLRY) are down 2.9% at $17.82 at last check, after the cannabis company announced the completion of its merger with sector rival Aphria (APHA).

Tilray Stock Drops After Finalizing Merger with Aphira

Canadian cannabis company Tilray Inc. said Monday its shares will continue to trade on Nasdaq under the ticker symbol "TLRY" after its merger with fellow Canadian cannabis company Aphria Inc. which shareholders approved on Friday, and will start to trade on the Toronto Stock Exchange under the same ticker from May 5. The companies are expecting the new combined company, the world's biggest cannabis company measured by revenue, to generate pretax cost-saving synergies of $81 million with 18 months of closing.

Tilray says shares will start trading on Toronto Stock Exchange from May 5 after Aphria merger approved

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) and Aphria Inc. (“Aphria”) today announced the completion of the previously announced business combination, ushering in a new era in the global cannabis industry. The combined company, which will operate as Tilray (the “Company”), brings together two highly complementary businesses to create the leading cannabis-focused consumer packaged goods (“CPG”) company with the largest global geographic footprint in the industry. Th

Tilray & Aphria Announce Closing of Transaction That Creates the “New” Tilray – a Global Cannabis Leader

Canadian Cannabis Stocks For Your Portfolio In May The post Are These The Top Canadian Marijuana Stocks To Buy Next Week? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Top Canadian Marijuana Stocks To Buy Next Week?

Tilray Inc. shareholders voted to approve the Canadian cannabis company's proposed merger with Aphria Inc. at a special meeting on Friday, according to media reports, paving the way for the creation of the world's biggest cannabis company measured by revenue. The move was widely expected after Aphria shareholders voted in favor of a deal by a wide margin, with a total of 99.38% of shares voted approving it on April 14.

Tilray shareholders approve Aphria merger, creating world's biggest cannabis company by revenue

Akerna Corp

Philip Morris

Pyxus International Inc

These 10 Pot Stocks Smoked the Last Week of April

Expect the Tilray-Aphria merger to be approved on April 30. But TLRY stock will likely fall once the merger goes through since it may take time for synergies to work.

Tilray Stock Will Fall Following the Aphria Merger on April 30

News for Tilray Brands Stock (TLRY)